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Purpose/Objective: To determine if a weekly cone-beam CT 
(CBCT) is enough to evaluate the entire tumor inclusion and 
the reproducibility throughout the radiation course treatment 
in lung cancer. 
Materials and Methods: Thirty-six lung cancer patients were 
treated with image-guided radiotherapy (IGRT) on an Elekta 
Synergy Beam Modulator linear accelerator.  
The GTV included the tumor and the positive nodes in PET-CT 
and pathologic analysis. The PTV was configured with the 
GTV and a margin of 0.7 cm – 1 cm in all directions. 
In our protocol of lung cancer treatment, prior to each 
radiotherapy fraction we make one cone-beam CT every day 
on the first five days of treatment using automated soft-
tissue registration. The positional errors of the reference 
image in relation to the acquired image (given in terms of 
translation movements) were obtained. No rotations were 
permitted. The average of these translational movements in 
the three axes (x, y, z) was calculated. This average was 
applied from the sixth day of treatment until the end. 
Weekly image guidance was registered resulting in at least 10 
CBCT scans for each patient. The deviations in the three axes 
in every weekly CBCT with respect to the average were 
analyzed (Tx, Ty, Tz) 
Results 
The graphics summarize the result of our analysis.  
 
 
In 29 patients (80.6%) the mean value of the difference 
between the positional errors compared to the average was: 
x = (0.19 ± 0.14) cm, y = (0.21 ± 0.14) cm, z = (0.27 ± 0.16) 
cm. All these values were less than 0.5cm and were 
considered correct for the suitable treatment of the patients. 
The shifts in the z axis showed more variability compared to 
the other axes mainly related to breathing movements. 
Nevertheless this z axis variability did not influence on the 
entire tumor inclusion and the set up reproducibility. 
In the other 7 patients (19.4%) we obtained a greater 
difference in either axes, and a CBCT more often than once a 
week was evaluated by the physician. 
Conclusions: Our preliminary results showed that in most 
lung cancer patients treated with IGRT, once an average is 
calculated after the first five days of treatment, a weekly 
cone-beam CT is enough to evaluate the entire tumor 
inclusion and the reproducibility throughout the radiation 
treatment. 
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Purpose/objective: Recent innovations in Radiation Oncology 
demand a higher implication of radiation technologists (RTTs) 
in imaging verification. Certain complex breast cancer 
treatments, and partial breast irradiation, may require 
image-guided radiotherapy (IGRT) with daily imaging. This 
creates a need to train RTTs to perform reliable online 
imaging evaluations, which would equally recognize their 
expertise and optimize human resources. The aim of this 
study is to evaluate the effectiveness of a training program in 
electronic portal imaging (EPI) for RTTs.    
Material/methods: This training project had a theoretical 
component, a single day lecture program; and a practical one 
to one session between the radiation oncologist and the RTT. 
The impact of the theoretical module was assessed by an 
evaluation before and after the lessons, via an online survey 
service. For the practical module, an RTT specific file in the 
online survey service allowed access from every treatment 
unit, data input of the difference between the radiation 
oncologist and the RTT EPI verification and the radiation 
oncologist evaluation and auto-evaluation of the RTT skills in 
EPI guided patient positioning.  
Results: An initial analysis has been performed in September 
2014 with twenty RTTs on 39 breast cancer cases, 129 
images, evaluated by one radiation oncologist. A significant 
(p < 0.05) improvement was shown between the pre and the 
post-theoretical module evaluation by the ANOVA test (Fig 
1). When assessed by the radiation oncologist, 87.2% of RTTs 
had acquired expert skills in EPI evaluation, and 12.8% had 
assimilated how to evaluate EPIs. This percentage lowered 
when autoassesed by the RTT to 66.7% for expert and grew to 
33.3% for assimilated skills. As for the margin of error, a 
deviation of > 3mm  ≤ 5mm of the RTT verification with 
respect to the radiation oncologist verification was found in 
only 4 images in the X axe (3% of the total images) and for 9 
images in the Y axe (7%). There were no deviations of > 5mm 
with respect to the radiation oncologist EPI validation. The 
post-training satisfaction questionnaire showed an overall 
average satisfaction of 3.35/4 (Table 1).   
Conclusion: This training methodology seems feasible and 
shows excellent results both in terms of theoretical and 
practical skills in EPI evaluation. This allows RTTs to develop 
their skills in EPI evaluation and be autonomous. An online 
evaluation questionnaire is an effective tool to assess the 
immediate educational impact. This model is promising for 
training for IGRT imaging evaluation.  
 
Fig. 1. In red pre-theoretical module evaluation answers to 
31 multiple-choice questions. In blue the post-theoretical 
module answers to the same evaluation. Results expressed in 
the average percentage of correct answers per question.    
 
 
 
The course that you have attended: Average 
score 
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Was in accordance with your expectations?   
3,08 
Did it take place in a favorable working 
environment? 
  
3,70 
Were the methods adapted to the objectives?   
3,27 
May it entail positive modifications in your 
professional exercise? 
  
3,29 
Does it deserve to be recommended to your 
colleagues? 
  
3,56 
Interest of the subject 3.27 
Quality of the presentation 3.31 
 
Table 1. Average results of the satisfaction questionnaire, 
with answers scored from 0-4, being 0: no satisfaction; and 4: 
extreme satisfaction. 
 
Stereotactic body radiation therapy for localized prostate 
cancer: institutional experience 
R. García García, I. Marrone, I. Santaolalla,V. Ascary, G. 
Heinrich 
  
Introduction: Stereotactic body radiotherapy (SBRT) is a 
radiation technique designed to administer precisely directed 
high-dose irradiation that tightly conforms the target, in 
order to create a desired radiobiologic response with tumor-
ablative intent, while minimizing radiation dose to 
surrounding normal tissue, within an image-guided course of 
treatment that does not exceed 5 fractions. SBRT in the 
treatment of localized prostate cancer is widely accepted, 
being the second extracranial malignancy treated with this 
technique, with excellent biochemical control rates and low 
and acceptable toxicity outcomes. 
Purpose: To report preliminary clinical and dosimetric 
analysis of stereotactic body radiotherapy treatment for 
organ-confined prostate cancer in a period of 3 years. 
Material/methods: >From May 2011 through May 2014 a total 
of 13 patients with clinically localized prostate cancer were 
treated using a CyberKnife. Four intraprostatic fiducial marks 
were placed via transrectal ultrasound, two at the prostate 
apex and two at the base separated at least by 2 cm, and 
controlled with orthogonal radiography. After five days 
allowing time for possible seed migration, treatment planning 
was performed using a CT scan (1.25 mm). The course of 
radiotherapy consisted of 5 daily fractions of 7.25 Gy for a 
total dose of 36.25 Gy to the prostate PTV; considered an 
α/β of 1.5 the DEQ2Gy results 90.6 Gy. The PTV was defined 
extending the margin of prostate CTV 5 mm on all sides 
except for posteriorly (by the rectum) where a 3 mm margin 
was used. 
Results: Ten patients were low-risk (77%), intermediate-risk 
(23%). The median prescription isodose was 83% [80-87%], the 
prescribed dose reached a median GTV coverage of 99.95% 
[99.84-100%] and PTV coverage of 96.1% [95.1-97.1%]. 
With a median follow-up of 18 months there was no patient 
with PSA failure, showing a progressive reduction in all of 
them. 
Acute Grade I and II urinary toxicities occurred in 32% and 
18% of patients respectively, only 7% of Grade I late urinary 
toxicities were observed with no higher Grade. Rectal acute 
Grade I and II complications were observed in 23% and 7% of 
patients, and no late toxicity. No patients experienced 
Radiation Therapy Oncology Group Grade III or IV 
complications, both late and acute. 
Conclusions: The current evidence supports consideration of 
stereotactic body radiotherapy among the therapeutic 
options for localized prostate cancer. In well selected 
patients SBRT’s advantages of noninvasiveness, delivery 
without anesthesia or hospitalization and its outcomes, 
compares favorably this technique with other definitive 
treatments. The low toxicity and maintained reduction in PSA 
values seen in this serie are highly encouraging, and 
additional follow-up is needed to determine long-term 
biochemical control and maintenance of low toxicity. 
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